These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency. Fu HX, Liu XY, Wang ZQ, Jin M, Wang DN, He JJ, Lin MT, Wang N. Neurol Sci; 2016 Jul 27; 37(7):1099-105. PubMed ID: 27000805 [Abstract] [Full Text] [Related]
7. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report. Goh LL, Lee Y, Tan ES, Lim JSC, Lim CW, Dalan R. BMC Med Genomics; 2018 Apr 03; 11(1):37. PubMed ID: 29615056 [Abstract] [Full Text] [Related]
15. Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation. Wen B, Li D, Shan J, Liu S, Li W, Zhao Y, Lin P, Zheng J, Li D, Gong Y, Yan C. Mol Genet Metab; 2013 Jun 03; 109(2):154-60. PubMed ID: 23628458 [Abstract] [Full Text] [Related]
19. Amelioration of acylcarnitine profile using bezafibrate and riboflavin in a case of adult-onset glutaric acidemia type 2 with novel mutations of the electron transfer flavoprotein dehydrogenase (ETFDH) gene. Shioya A, Takuma H, Yamaguchi S, Ishii A, Hiroki M, Fukuda T, Sugie H, Shigematsu Y, Tamaoka A. J Neurol Sci; 2014 Nov 15; 346(1-2):350-2. PubMed ID: 25216552 [No Abstract] [Full Text] [Related]
20. Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report. Wang J, Wu JC, Yu XE, Han YZ, Yang RM. Medicine (Baltimore); 2018 Nov 15; 97(48):e13153. PubMed ID: 30508893 [Abstract] [Full Text] [Related] Page: [Next] [New Search]